Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Singleton who wrote (3608)	1/14/1998 3:27:00 PM
From: Tom DuBois	of 6136

To all: I haven't posted in awhile but am still very long AGPH. Got killed in the Nov options debacle though. My questions have to do with European approval. 1. Why is it taking so long? It would seem that with US approval in, sales of V-Cept skyrocketing and all the anecdotal evidence being positive, there would be great pressure on the European equivalent of the FDA to speed approval. Perhaps it is a bureaucratic snag for which the EC is so famous. Perhaps the European HIV community is not as vocal/influential as ours. At any rate, it seems to be taking longer than one would expect. 2. Are European profits figured into any of the analysts earnings estimates?? How about LMoss' or Billkirn's? Near -term price action looks good. Now we need more good news. Good luck to all. Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next